‘One-of-a-kind’ new Alzheimer’s drug shows promise: ‘An exciting development’
“This research is taking promising steps towards a new one-of-a-kind therapy which targets tau, a damaging protein in the brains of people living with Alzheimer’s, preventing it from clumping together,” said Richard Oakley, associate director of research and innovation at the Alzheimer’s Society UK, which funded the research.
New Alzheimer’S Drug Shows Promise To Prevent Buildup Of Tau Proteins In Brain Cells
In a promising breakthrough, an international team of researchers from the UK, US, and Japan has developed a new Alzheimer's
Promising Breakthrough in Alzheimer's Drug Development
For the first time, scientists have developed a drug that works on both major aggregation-promoting "hotspots" of the Tau protein - addressing a critical gap in current treatments.
Alzheimer’s breakthrough after drug treatment success
Alzheimer’s breakthrough after drug treatment success - The study found that the medication, called RI-AG03, was effective at preventing the build-up of Tau proteins
Breakthrough Alzheimer’s Drug Prevents Toxic Protein Build-up In Brain
Researchers from a study funded by the Alzheimer’s Society of UK have developed a new drug known as RI-AG03 that they say can prevent the build-up of toxic proteins in the brain that lead to neurodegenerative issues causing Alzheimer’s disease.
First-of-its-kind Alzheimer's drug offers hope of treatment
Developed by international researchers led by British experts, RI-AG03, tackles two 'hotspots' on the protein that leads to the memory robbing condition getting worse.
New study is a promising ‘first’ in Alzheimer’s drug development
New study is a promising ‘first’ in Alzheimer’s drug development - Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative diseases.
Promising Alzheimer's drug candidate prevents buildup of tau proteins in lab and fruit fly studies
An international team of researchers led by Lancaster University has made a promising breakthrough in the development of ...
Neuroscience News11h
Dual-Targeting Drug Halts Tau Accumulation in Alzheimer’s
Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...
Alzheimer’s Game Changer: Dual-Action Drug Attacks Disease at Its Core
AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.
EurekAlert!13h
Promising ‘first’ in Alzheimer’s drug development
An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...
Alzheimer's breakthrough as scientists discover drug that blasts memory robbing hotspots
In people with Alzheimer's disease, they clump together, starve brain cells of nutrients and slow down signals in the organ ...
Science Daily13d
New therapy that targets and destroys tau tangles is a promising future Alzheimer's disease treatment
Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with Alzheimer's disease, and improve symptoms of neurodegeneration in mice.
EurekAlert!19h
Imaging (IMAGE)
Scientists used a special imaging technique to observe how Tau protein clumps in the brain tissue of genetically modified ...
Key mechanisms in asymptomatic Alzheimer's disease brains offer potential protection against cognitive decline
Researchers at Indiana University School of Medicine are examining the brains of individuals with asymptomatic Alzheimer's ...